Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $923.15 MXN
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:09 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kenneth C. Frazier

Chairman, Chief Executive Officer and President,Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 41 board members in 3 different organizations across 3 different industries.

See Board Relationships
60$25,029,370
As of Fiscal Year 2014

Background*

Mr. Kenneth C. Frazier, also known as Ken, has been the President of Merck & Co. Inc. since May 01, 2010 and has also been its Chief Executive Officer since January 1, 2011. Mr. Frazier served as the President of Global Human Health at Merck & Co. Inc. since August 1, 2007. Mr. Frazier served as an Executive Vice President of Merck & Co., Inc. since November 2006. He served as Senior Vice President of Merck & Co. Inc. from December 1999 to November 2006 and General Counsel ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

Director
2009-Present
Director, Chairman of Board Affairs Committee and Member of Public Issues & Contributions Committee
2011-Present
Chairman, Chief Executive Officer and President

Education*

BA 1975
Pennsylvania State University
JD 1978
Harvard Law School

Other Affiliations*

Annual Compensation*

Salary$1,500,000
Total Annual Compensation$1,500,000

Stock Options*

Restricted Stock Awards$13,025,313
All Other Compensation$197,402
Exercised Options160,878
Exercised Options Value$1,355,305
Exercisable Options2,227,293
Exercisable Options Value$42,630,377
Unexercisable Options1,211,187
Unexercisable Options Value$9,123,796
Total Value of Options$53,109,478
Total Number of Options3,599,358

Total Compensation*

Total Annual Cash Compensation$5,038,652
Total Short Term Compensation$1,500,000
Other Long Term Compensation$13,222,715
Total Calculated Compensation$25,029,370
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK*:MM $923.15 MXN 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.